Low serum glycine strengthens the association between branched-chain amino acids and impaired insulin sensitivity assessed before and after weight loss in a population with pre-diabetes: The PREVIEW_NZ cohort

Clin Nutr. 2024 Dec;43(12):17-25. doi: 10.1016/j.clnu.2024.09.047. Epub 2024 Oct 2.

Abstract

Aim: Accumulation of circulating branched-chain amino acids (BCAA) is a hallmark feature of impaired insulin sensitivity. As intracellular BCAA catabolism is dependent on glycine availability, we hypothesised that the concurrent measurement of circulating glycine and BCAA may yield a stronger association with markers of insulin sensitivity than either BCAA or glycine alone. This study therefore examined the correlative relationships of BCAA, BCAA and glycine together, plus glycine alone on insulin sensitivity-related markers before and after an 8-week low energy diet (LED) intervention.

Methods: This is a secondary analysis of the PREVIEW (PREVention of diabetes through lifestyle Intervention and population studies in Europe and around the World) Study New Zealand sub-cohort. Eligible participants with pre-diabetes at baseline who achieved ≥8 % body weight loss following an LED intervention were included, of which 167 paired (Week 0 and Week 8) blood samples were available for amino acid analysis. Glycemic and other data were retrieved from the PREVIEW consortium database. Repeated measures linear mixed models were used to test the association between amino acids and insulin sensitivity-related markers (HOMA2-IR, glucose, insulin, and C-peptide).

Results: Elevated BCAA was associated with impaired insulin sensitivity (p < 0.05), with strength of association (ηp2) almost doubled when glycine was added to the model. However, glycine in isolation was not associated with insulin sensitivity-related markers. The magnitude (β-estimates) of positive association between BCAA and HOMA2-IR, and inverse association between glycine and HOMA2-IR, increased when body weight was higher (Body weight∗BCAA, Body weight∗glycine, p < 0.05, both).

Conclusion: Low serum glycine strengthened the association between BCAA and impaired insulin sensitivity. Given that glycine is necessary to facilitate intracellular BCAA catabolism, measurement of glycine is necessary to complement BCAA analysis to comprehensively understand the contribution of amino acid metabolism in insulin sensitivity.

Clinical trial registration: This study was registered with ClinicalTrials.gov (NCT01777893).

Keywords: Branched-chain amino acid; Glycine; Insulin; Obesity; Pre-diabetes; Weight loss.

Publication types

  • Clinical Study

MeSH terms

  • Adult
  • Amino Acids, Branched-Chain* / blood
  • Biomarkers / blood
  • Blood Glucose / metabolism
  • Caloric Restriction / methods
  • Cohort Studies
  • Female
  • Glycine* / blood
  • Humans
  • Insulin / blood
  • Insulin Resistance*
  • Male
  • Middle Aged
  • New Zealand
  • Prediabetic State* / blood
  • Weight Loss*

Substances

  • Amino Acids, Branched-Chain
  • Biomarkers
  • Blood Glucose
  • Glycine
  • Insulin

Associated data

  • ClinicalTrials.gov/NCT01777893